Functional modulation of CD8+ T cell by approved novel immune enhancer: Nocardia rubra Cell-Wall Skeletons (Nr-CWS)

Y Tao, G Wang, J Zhai, N Zhang - International Immunopharmacology, 2020 - Elsevier
Nocardia rubra cell wall skeleton (Nr-CWS) has been reported to have innate
immunostimulating and anti-tumor activities. However, the immunomodulatory effects of Nr …

Nocardia rubra cell-wall skeleton promotes CD4+ T cell activation and drives Th1 immune response

G Wang, J Wu, M Miao, H Dou, N Nan, M Shi… - International journal of …, 2017 - Elsevier
Several lines of evidences have shown that Nocardia rubra cell wall skeleton (Nr-CWS) has
immunoregulatory and anti-tumor activities. However, there is no information about the effect …

[PDF][PDF] Enhancing natural killer cell-mediated cancer immunotherapy by the biological macromolecule nocardia rubra cell-wall skeleton

J Wu, B He, M Miao, X Han, H Dai, H Dou… - Pathology and …, 2022 - por-journal.com
The biological macromolecule Nocardia rubra cell-wall skeleton (Nr-CWS) has
wellestablished immune-stimulating and anti-tumor activities. However, the role of Nr-CWS …

The biological macromolecule Nocardia rubra cell‐wall skeleton as an avenue for cell‐based immunotherapy

Y Meng, J Sun, X Wang, Y Ma, C Kong… - Journal of Cellular …, 2019 - Wiley Online Library
Promoting the antitumor effects of cell‐based immunotherapy for clinical application remains
a difficult challenge. Nocardia rubra cell‐wall skeleton (N‐CWS) is an immunotherapeutic …

Nocardia rubra cell‐wall skeleton influences the development of cervical carcinoma by promoting the antitumor effect of macrophages and dendritic cells

S Zhang, H Wang, Y Liu, T Tao, Z Zeng… - Cancer …, 2022 - Wiley Online Library
Background As an immune enhancer, Nocardia rubra cell‐wall skeleton (Nr‐CWS) has
been used to treat persistent human papillomavirus infection and cervical precancerous …

Augmentative effect of Nocardia rubra cell-wall skeleton (N-CWS) on lymphokine-activated killer (LAK) cell induction

S Yokota, T Shirasaka, H Nishikawa, S Hosoe… - Cancer Immunology …, 1988 - Springer
The present study elucidated that N-CWS augments the cytolytic activity against 3LL tumor
cells of LAK cells from N-CWS-immunized mice administered ip with rIL-2. This …

[HTML][HTML] A TCM formula YYWY inhibits tumor growth in non-small cell lung cancer and enhances immune-response through facilitating the maturation of dendritic cells

B Zhao, X Hui, L Jiao, L Bi, L Wang, P Huang… - Frontiers in …, 2020 - frontiersin.org
In worldwide, lung cancer has a major socio-economic impact and is one of the most
common causes of cancer-related deaths. Current therapies for lung cancer are still quite …

[HTML][HTML] LunX-CAR T cells as a targeted therapy for non-small cell lung cancer

Z Hu, X Zheng, D Jiao, Y Zhou, R Sun, B Wang… - Molecular Therapy …, 2020 - cell.com
Non-small cell lung cancer (NSCLC) carries a high mortality, and efficacious therapy is
lacking. Therapy using chimeric antigen receptor (CAR) T cells has been used efficaciously …

Study on mechanism for immunoregulation of Shufeng Jiedu capsule.

L Ma, Y Huang, Y Hou, D Zhang, Y Zhang, J Liu… - 2019 - cabidigitallibrary.org
Objective To explore the immunoregulation of Shufeng Jiedu Capsule (SJC) and its
mechanism. Methods Using the Streptococcus pneumoniae (SP)-induced pneumonia rats …

Effects of periodic administration ofNocardia rubra cell-wall skeleton on immunoglobulin production and B-cell-stimulatory factor activity in vitro in workers at a poison …

S Hozawa, S Ishioka, J Yanagida, M Takaishi… - Cancer Immunology …, 1989 - Springer
The former workers at the Okunojima poison gas factory (poison gas workers) are a high-risk
group for malignant neoplasms and show abnormalities in cellular immunity. At the same …